glp-1 and eating disorders Treating Disorder Clients Amid the Craze: A Complex Landscape GLP-1 receptor agonists: A novel
Description
October 2023 : A study of 16 million patients (2006-2020) found that those who used GLP-1 agonists for weight loss were at a higher risk of pancreatitis, bowel obstruction, and gastroparesis compared to those who took bupropion-naltrexone instead
Try pausing before each meal and rating your hunger on a scale from one to ten
Shop Now Customers love Replenza Replenza is refreshing and light
Drucker DJ, Brubaker PL
Next, Ill talk about the GLP-1 debacle and what it means for HIMS moving forward
